Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase

The American Journal of Cardiology
F TatòScott M Grundy

Abstract

Marked lowering of plasma total and low-density lipoprotein cholesterol levels that occur during treatment of dyslipidemia with pharmacologic doses of nicotinic acid result from hepatotoxicity. Therefore, a marked reduction in low-density lipoprotein may suggest generalized liver toxicity and drug treatment should be discontinued.

References

Aug 1, 1989·Annals of Internal Medicine·G E MullinM C Mitchell
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Mar 2, 1994·JAMA : the Journal of the American Medical Association·J M McKenneyV M Chinchili

❮ Previous
Next ❯

Citations

Jun 7, 2005·Postgraduate Medical Journal·G D KolovouD V Cokkinos
May 1, 2013·Critical Reviews in Food Science and Nutrition·Anthony Fardet, Jean-Michel Chardigny
Dec 21, 2000·Current Atherosclerosis Reports·S Tavintharan, M L Kashyap
Apr 10, 2010·Preventive Cardiology·William Phillips, Saul Schaefer
Feb 10, 2006·Current Medical Research and Opinion·A VogtUNKNOWN NAUTILUS Study Group
May 23, 2012·Expert Opinion on Pharmacotherapy·Rahul YadavHandrean Soran
Dec 3, 2011·Expert Opinion on Drug Safety·Rahul YadavHandrean Soran
Apr 10, 2007·Annals of Emergency Medicine·Manoj K MittalKevin C Osterhoudt
Sep 1, 2008·Expert Review of Endocrinology & Metabolism·Lorenzo IughettiFiorella Balli
Apr 22, 2006·The Journal of Pharmacology and Experimental Therapeutics·Genovefa D KolovouDimitri P Mikhailidis
Mar 30, 1999·Journal of Computer Assisted Tomography·T Kristensen, E W Olcott
Nov 10, 2018·Hepatology Communications·Kenneth LeungNeil Kaplowitz
Mar 21, 2007·The American Journal of Cardiology·John R Guyton, Harold E Bays

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.